For breast cancer, we investigated the performance of our predictor relative to a univariate model using the expression of the AURKA gene as covariate, since this model serves as a robust benchmark for other breast cancer predictors [30], and two validated gene signature-based predictors [2, 3] (Fig 3B and Tables H-I in S1 File). The gene discussed is AURKA; the disease is breast cancer.